These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8313550)

  • 1. Low-dose aspirin inhibits platelet-induced contraction of the human isolated coronary artery. A role for additional 5-hydroxytryptamine receptor antagonism against coronary vasospasm?
    Bax WA; Renzenbrink GJ; van der Linden EA; Zijlstra FJ; van Heuven-Nolsen D; Fekkes D; Bos E; Saxena PR
    Circulation; 1994 Feb; 89(2):623-9. PubMed ID: 8313550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT receptors mediating contractions of the isolated human coronary artery.
    Bax WA; Renzenbrink GJ; Van Heuven-Nolsen D; Thijssen EJ; Bos E; Saxena PR
    Eur J Pharmacol; 1993 Aug; 239(1-3):203-10. PubMed ID: 7693489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.
    Maassen VanDenBrink A; Bax WA; Ferrari MD; Zijlstra FJ; Bos E; Saxena PR
    Br J Pharmacol; 1996 Nov; 119(5):855-62. PubMed ID: 8922732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serotonin, histamine, and thromboxane A2 in platelet-induced contractions of coronary arteries and aortae from rabbits.
    Awano K; Yokoyama M; Fukuzaki H
    J Cardiovasc Pharmacol; 1989 May; 13(5):781-92. PubMed ID: 2472528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries.
    Chester AH; Martin GR; Bodelsson M; Arneklo-Nobin B; Tadjkarimi S; Tornebrandt K; Yacoub MH
    Cardiovasc Res; 1990 Nov; 24(11):932-7. PubMed ID: 2272071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
    Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
    Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries.
    Chester AH; Allen SP; Tadjkarimi S; Yacoub MH
    Circulation; 1993 Mar; 87(3):874-80. PubMed ID: 8443908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between platelet-derived 5-hydroxytryptamine and arachidonic acid metabolites limits the thrombolytic efficacy of streptokinase against canine platelet-rich coronary thrombosis.
    Vandeplassche G; Hermans C; Van Dael L; Wouters L; De Clerck F
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):56-69. PubMed ID: 7678680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclins are only weak antagonists of coronary vasospasm induced by authentic thromboxane A2 and serotonin.
    Schrör K; Verheggen R
    J Cardiovasc Pharmacol; 1986; 8(3):607-13. PubMed ID: 2425180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modification of platelet-induced coronary vasoconstriction by a thromboxane receptor antagonist.
    Verheggen R; Schrör K
    J Cardiovasc Pharmacol; 1986; 8(3):483-90. PubMed ID: 2425162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different interactions of platelets with arterial and venous coronary bypass vessels.
    Yang ZH; Stulz P; von Segesser L; Bauer E; Turina M; Lüscher TF
    Lancet; 1991 Apr; 337(8747):939-43. PubMed ID: 1678031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
    Kaumann AJ; Frenken M; Posival H; Brown AM
    Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
    Cocks TM; Kemp BK; Pruneau D; Angus JA
    Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-induced hypercontraction through 5-hydroxytryptamine 1B receptors in atherosclerotic rabbit coronary arteries.
    Ishida T; Kawashima S; Hirata Ki ; Sakoda T; Shimokawa Y; Miwa Y; Inoue N; Ueyama T; Shiomi M; Akita H; Yokoyama M
    Circulation; 2001 Mar; 103(9):1289-95. PubMed ID: 11238275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine.
    McGoon MD; Vanhoutte PM
    J Clin Invest; 1984 Sep; 74(3):828-33. PubMed ID: 6470141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-induced contractions in canine coronary arteries.
    Li P; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1065-70. PubMed ID: 9190837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.